From left: Mr. Sean Kirk, Founder & CEO of Rehouzd, and Mr. Ragul Shanmugam, Co-Founder & CTO of Rehouzd.

Explore essential resources for administering Purdue’s graduate programs — including Graduate Council meeting dates & minutes. Access proposal guidelines, academic policies, and systemwide tools that ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Commercial real estate can be considered something of a tale of two cities, with some asset classes—like office space—struggling to sustain demand from tenants, investors and lenders, whereas ...

The best real estate ETFs (exchange-traded funds) let you invest in professionally managed portfolios of real estate operating companies and real estate investment trusts (REITs) without actually ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Real Madrid are set to oversee a defensive revolution this summer, and understandably so given how they were frustrated in the department throughout last season. Even Antonio Rudiger, who was ...

Let’s start with college graduates, because that is where the AI fear is loudest. The Federal Reserve Bank of New York reported recent-grad unemployment at 5.7 percent in Q4 2025, with underemployment ...

Adriana Orozco’s journey into real estate development has been shaped by a blend of early inspiration, intentional career decisions, and a commitment to continuous growth. Currently enrolled in ...

As climate change drives more frequent extreme heat and worsening air pollution, researchers are seeking better ways to understand how these exposures affect health in real time. A new pilot study led ...

Even if you have experience with real estate investing, the reality is you probably aren't an expert. Real estate investors ...

Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...